Nucleotide Analogues as Inhibitors of SARS-CoV‑2 Polymerase, a Key Drug Target for COVID-19

Abstract excerpt

SARS-CoV-2 is responsible for the current COVID-19 pandemic. On the basis of our analysis of hepatitis C virus and coronavirus replication, and the molecular structures and activities of viral inhibitors, we previously demonstrated that three nucleotide analogues (the triphosphates of Sofosbuvir, Alovudine, and AZT) inhibit the SARS-CoV RNA-dependent RNA polymerase (RdRp). We also demonstrated that a library of...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to SARS-CoV-2 and COVID-19 Research
• Share to Viral gastroenteritis research and epidemiology
• Share to Viral Infections and Immunology Research